BeStock  
Stocks › Biotechnology › INVA

Innoviva INVA

US equityMarket cap rank #2978Biotechnology
$18.41 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.41 0.00%
Open$18.41
Prev close$18.41
Day range$18.33 – $18.79
Volume1.15M
Market cap$1.31B
P/E (TTM)7.8
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership109.4%+1.76 pts vs. prior quarter
Institutions holding376-3 vs. prior quarter
Insider trades (recent)34 buys / 16 sellsNet buying
Short interest10.37% of floatDays to cover 12.9 · as of 30 Oct 2026
Short-sale volume share18.5%5-day average of daily volume

Short-sale volume as % of daily volume

11%16%21%26%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$4.39M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

+$2.8MSuper+$1.6MBig+$1.7MMid+$1.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.0% of shares outstanding.

Largest holders

  • BlackRock15.67%
  • Dimensional Fund Advisors6.35%
  • Vanguard Portfolio Management, LLC5.88%
  • Renaissance Technologies Corp.5.14%
  • State Street Global Advisors4.92%
  • Vanguard Capital Management, LLC4.46%
  • Millennium Management LLC3.57%
  • The Bank of Nova Scotia3.07%

By investor type

  • Mutual Fund76.92%
  • Hedge Fund17.82%
  • Public Company10.98%
  • Private Company1.58%
  • Government Pension Fund1.21%
  • Individual/Insider0.76%
  • Insurance Company0.65%
  • Family Office/Trust0.07%

Reported short interest has risen from 9.50% to 10.37% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
UBS Asset Management Mutual Fund 2026/Q3 +503,481 1.7%
Morgan Stanley Public Company 2026/Q3 +501,081 2.4%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +501,081 2.4%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +455,427 1.6%
State Street Global Advisors Mutual Fund 2026/Q3 +231,690 4.9%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +218,313 0.3%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +190,705 1.2%
Deutsche Bank Aktiengesellschaft Public Company 2026/Q3 +175,655 1.4%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +148,708 0.2%
AssetMark, Inc. Mutual Fund 2026/Q3 +139,361 0.5%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +70,381 0.7%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +151,229 0.6%
Bridgeway Capital Management, LLC Mutual Fund 2026/Q3 +501,318 0.7%
Robert W. Baird & Co. Incorporated Private Company 2026/Q3 +274,391 0.4%
Jane Street Group, LLC Private Company 2026/Q3 +270,938 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
19 Aug 2026 Marianne Zhen Chief Accounting Officer & Secretary Sale to Issuer -1,127 $21.00 56,389
19 Aug 2026 Pavel Raifeld Chief Executive Officer Sale to Issuer -1,130 $21.00 24,356
19 Aug 2026 Stephen Bassock Sale to Issuer -558 $21.00 11,268
19 May 2026 Marianne Zhen Chief Accounting Officer & Secretary Sale to Issuer -1,127 $22.24 57,516
19 May 2026 Pavel Raifeld Chief Executive Officer Sale to Issuer -1,130 $22.24 23,150
19 May 2026 Stephen Bassock Sale to Issuer -559 $22.24 10,410
17 May 2026 Josephine Linden Independent Director Other Acquisition +15,194 – 15,194
17 May 2026 Josephine Linden Independent Director Other Derivative Acquisition +9,166 $21.80 9,166
14 May 2026 Pavel Raifeld Chief Executive Officer Other Acquisition +1,123 – 23,150
14 May 2026 Stephen Bassock Other Acquisition +1,123 – 10,410
3 May 2026 Jules Haimovitz Independent Director Other Acquisition +9,786 – 9,786
3 May 2026 Jules Haimovitz Independent Director Other Derivative Acquisition +10,000 $22.99 10,000
3 May 2026 Derek Small Former Independent Director Other Acquisition +9,786 – 9,786
3 May 2026 Derek Small Former Independent Director Other Derivative Acquisition +10,000 $22.99 10,000
3 May 2026 Marianne Zhen Chief Accounting Officer & Secretary Other Acquisition +12,766 – 58,643
3 May 2026 Marianne Zhen Chief Accounting Officer & Secretary Other Derivative Acquisition +31,500 $22.99 31,500
3 May 2026 Sarah Schlesinger Independent Director Other Acquisition +9,786 – 9,786
3 May 2026 Sarah Schlesinger Independent Director Other Derivative Acquisition +10,000 $22.99 10,000
3 May 2026 Mark DiPaolo Former Independent Chairperson Other Acquisition +9,786 – 9,786
3 May 2026 Mark DiPaolo Former Independent Chairperson Other Derivative Acquisition +10,000 $22.99 10,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,495,210 10.4% 12.9
15 Oct 2026 7,265,728 10.1% 10.4
30 Sep 2026 6,845,485 9.5% 5.7
15 Sep 2026 7,144,265 9.9% 9.3
31 Aug 2026 6,940,337 9.6% 11.8
14 Aug 2026 6,864,277 9.5% 9.2

Discussion

No comments yet — be the first to weigh in on INVA.

Sign in to join the discussion.

Scroll to Top